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Background: Promoting a healthy lifestyle (eg, physical activity, healthy diet) is crucial for the primary and secondary prevention
of cardiac disease in order to decrease disease burden and mortality.
Objective: The current trial aims to evaluate the effectiveness of the Do Cardiac Health: Advanced New Generation Ecosystem
(Do CHANGE) service, which is developed to assist cardiac patients in adopting a healthy lifestyle and improving their quality
of life.
Methods: Cardiac patients (ie, people who have been diagnosed with heart failure, coronary artery disease, and/or hypertension)
will be recruited at three pilot sites (Badalona Serveis Assistencials, Badalona, Spain [N=75]; Buddhist Tzu Chi Dalin General
Hospital, Dalin, Taiwan [N=100] and Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands [N=75]). Patients will be assisted
by the Do Something Different (DSD) program to change their unhealthy habits and/or lifestyle. DSD has been developed to
increase behavioral flexibility and subsequently adopt new (healthier) habits. In addition, patients’ progress will be monitored
with a number of (newly developed) devices (eg, Fitbit, Beddit, COOKiT, FLUiT), which will be integrated in one application.
Results: The Do CHANGE trial will provide us with new insights regarding the effectiveness of the proposed intervention in
different cultural settings. In addition, it will give insight into what works for whom and why.
Conclusions: The Do CHANGE service integrates new technologies into a behavior change intervention in order to change the
unhealthy lifestyles of cardiac patients. The program is expected to facilitate long-term, sustainable behavioral change.
Trial Registration: Clinicaltrials.gov NCT03178305; https://clinicaltrials.gov/ct2/show/NCT03178305 (Archived by WebCite
at http://www.webcitation.org/6wfWHvuyU).
(JMIR Res Protoc 2018;7(2):e40)   doi:10.2196/resprot.8406
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Cardiovascular diseases are the leading cause of death
worldwide and a major driver of health care costs [1]. Evidence
shows that a large proportion of the disease burden can be
explained by behavioral factors (eg, low physical activity,
unhealthy diet) [2], and that approximately 80% of heart disease,
stroke, and type 2 diabetes can be prevented by attenuating or
eliminating these health risk behaviors [3,4]. Hence, in their
recent call for action, the American Heart Association stressed
the importance of lifestyle management and called for better
lifestyle counseling and the development of interventions to
support health behavior change in cardiac patients [5].
Despite evidence showing that changing health behaviors
improves (mental) health outcomes and lowers health care costs
[5], to date, lifestyle counseling is not routinely implemented
in physicians’ office [6]. More precisely, physicians provide
this type of counseling in only 34% of the clinic visits [7]. One
of the important reasons for this is the fact that face-to-face
counseling is time-consuming.
Remote technologies offer a new delivery model for promoting
healthy behaviors and are increasingly used in health care
settings [8]. Although these new developments provide an
excellent opportunity to deliver behavior change interventions
to large groups of underserved patients, the reported effect sizes
have been small [8]. Possible explanations for this are the short
duration of the interventions [8], the limited number of
health-related behaviors addressed within the intervention
program [9], the mismatch between patients’ needs or
preferences and the intervention, or the lack of sound behavior
change methods adopted [10]. Previous trials within the cardiac
population have demonstrated that a “one size fits all” approach
does not seem to work [11]—revealing the importance of
personalizing the care plan and addressing patients’ needs and
preferences.
Evidence shows that the conventional way of providing
education about a healthy lifestyle does not result in adopting
desirable health behaviors [12]. In order to produce sustainable
change in health behaviors, the Do Cardiac Health: Advanced
New Generation Ecosystem (Do CHANGE) study will provide
a personalized theory-based behavior intervention program for
three months, creating awareness of unhealthy behaviors,
addressing multiple health behaviors at the same time, and
changing unhealthy habits. [13].
The Do CHANGE service aims to address cardiac patients’
unhealthy habits and change these by providing them with
monitoring tools (eg, Fitbit) and increasing their behavioral
flexibility. The Do Something Different (DSD) behavior change
program will be provided, with the objective of disrupting the
habit chains that are common in our daily living. Since people
generally tend to live in accordance with their habits [14],
disrupting these habits may lead to higher behavioral flexibility
and eventually to behavior change [13]. The DSD program has
been shown to be effective in changing health behaviors in
previous studies targeting different populations [15]. The Do
CHANGE service will, therefore, not only provide patients with
innovative tools to support behavior change, but will also offer
behavioral alternatives and carefully assess patients’ needs on
using these innovative tools.
The objective of the current trial is to evaluate the effectiveness
of the personalized Do CHANGE service in changing unhealthy
lifestyle and improving the quality of life in cardiac patients.
The Do CHANGE service will be developed and evaluated in
three different countries (Spain, Taiwan, The Netherlands), in
order to represent patients from different cultural backgrounds.




Do CHANGE is an international (Spain, Taiwan, The
Netherlands), multicenter, randomized (intervention versus care
as usual) controlled trial designed to support lifestyle change
in patients with cardiac disease. By increasing patients’
behavioral flexibility and providing them with innovative
devices, the objectives of enhancing lifestyle change and
improving patients’ quality of life are expected to be reached.
The evaluation of the Do CHANGE service delivery consists
of two randomized controlled trials—trial 1 (Do CHANGE),
which has been registered on www.clinicaltrials.gov
(NCT02946281), has provided input for the further development
and improvement of the currently described trial 2 (Do
CHANGE 2, NCT03178305).
Study Population
Patients primarily diagnosed with coronary artery disease (CAD)
(having experienced a myocardial infarction, percutaneous
coronary intervention, angina pectoris and/or coronary artery
bypass graft surgery), symptomatic heart failure (HF) (New
York Heart Association class I-IV), and patients diagnosed with
hypertension (HT) will be included in the study. Hypertension
is defined by values ≥140 mmHg of systolic blood pressure or
≥90 mmHg of diastolic blood pressure in two different
measurements spaced 1-2 minutes apart and after 3-5 minutes
in the sitting position. The values associated with the second
measure will be used.
Inclusion criteria: Age 18-75 years, diagnosed (primary
diagnosis) with CAD, HF or HT, having at least two of the
following risk factors: smoking, positive family history,
increased cholesterol, diabetes, sedentary lifestyle, and/or
psychosocial risk factors. Patients should also have access to
the Internet at home, have a smartphone which is compatible
with the applications that will be used in the study (and have
sufficient knowledge on using a personal computer and
smartphone), and speak the countries’ native language.
Additional inclusion criteria for only HF patients include a
diagnosis of systolic or diastolic heart failure and presence of
HF symptoms (eg, shortness of breath, chest pain, and
exhaustion).
Exclusion criteria: Significant cognitive impairments (eg,
dementia), patients who are on the waiting list for heart
transplantation, life expectancy <1 year, life-threatening
comorbidities (eg, cancers), with a history of psychiatric illness
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excluding anxiety and/or depression, patients who do not have
access to the Internet or a compatible smartphone, and patients
with insufficient knowledge of the local language (Catalonian,
Chinese or Dutch). Patients who have participated in the first
phase of the Do CHANGE trial will also be excluded.
Sample Size
A total number of 250 patients will be enrolled in the study at
three participating centers (Badalona Serveis Assistencials,
Badalona, Spain [N=75]; Buddhist Tzu Chi Dalin General
Hospital, Dalin, Taiwan [N=100] and Elisabeth-TweeSteden
Hospital, Tilburg, The Netherlands [N=75]). The sample sizes
were determined based on the number of patients visiting the
outpatient clinic per center.
One hundred and twenty-five patients will be enrolled in the
intervention group and 125 in the control group. Considering
participation rates in the previously performed Do CHANGE
trial and other randomized controlled trials, we expect a
significant number (50%) of patients to refuse participation.
Hence, we will need to approach 500 patients. As the current
trial aims to provide a proof of concept, sample size calculation
will not be performed. A total of 250 patients is considered
sufficient to meet this purpose.
Randomization
Patients will be randomized (2:2) to either the intervention group
or the control group (ie, usual care). Patients will be randomized
using computerized block randomization (stacks of 4). The
computer will generate randomization sequences that will be
sealed by an independent researcher. Due to the nature of the
study, the blinding of the researchers and health care providers
is not possible.
Study Procedure
Patients who fulfill all the inclusion criteria and none of the
exclusion criteria will be approached for participation. Due to
differences in health care implementation across the three
participating countries, the logistics of patient recruitment per
site might slightly differ.
Overall Procedure
The health care professional (cardiologist or cardiac nurse) will
inform the patient about the study (orally and in writing).
Patients who are willing to participate will be provided with an
informed consent and will be given ten days to consider their
participation. The research assistant will contact the patients by
telephone and schedule a face-to-face appointment if they are
willing to participate. During the face-to-face meeting, patients
will sign the informed consent (together with the researcher)
and will fill in the first set of questionnaires (shown in Table
1).
After completing the questionnaires, they will be randomized
to either the intervention or “care as usual” group. Patients
randomized to the intervention group will be provided with
tools (as described in the “Intervention” section) and instructions
on how to use them. Relevant tools and/or applications will be
installed on patients’ mobile phone by the research assistant
such that the patients will only have to charge the devices. One
day after the face-to-face meeting, patients will be contacted by
the research assistant by telephone to ensure that all devices are
properly charged and that the system is functional. The full
intervention (as described below) will be provided for three
months. During this period patients will be contacted weekly
by the research assistant to evaluate their progress (whether








xxxLifestyle52Health Promoting Lifestyle Profile [16]
xxxBehavioral flexibility45Do Something Different
xxxQuality of life26World Health Organization quality of life questionnaire [17]
xUsability of tools; acceptance of tools; willingness to
paya
28Unified Theory of Acceptance and Use of Technology [18]
xxxCost-effectiveness5EuroQOL questionnaire [19]
xxxHealth care consumption4Purpose designedb
xxxDepression9Patient Health Questionnaire [20]
xxxAnxiety7Generalized Anxiety Disorder scale [21]
xxxType D personality14Distressed Personality scale [22]
xPatient perceived satisfactiona8Client Satisfaction Questionnaire [23]
aThese 3 constructs will only be assessed in the intervention group.
bDesigned by the authors.
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Figure 1. Study procedure.
After the three months period, the behavior change component
(the DSD program) will be terminated. Hence, between months
3 and 6, patients in the intervention group will only be using
the devices that were provided to them at baseline. In addition,
to decrease patient burden, some of the tools and/or components
will be introduced two months after baseline measurement (see
Figure 1 for a schematic overview of the study procedure).
Patients will be instructed to fill in the first set of questionnaires
during their face-to-face visit at the hospital. At 3 and 6 months,
the patients will receive a link (by email) to access the follow-up
questionnaires online with the instruction to complete them
within ten working days. If they do not complete the
questionnaires within the given time, patients will receive up
to three reminder phone calls.
Patients who have been randomized to the intervention group
will also be contacted between months 3 and 6 to participate in
a qualitative survey (if possible with their partner), which will
assess additional properties of the usability and acceptability of
the tools.
Study Objectives
Primary, secondary and exploratory objectives will be assessed
as described below.
Primary Objectives
Primary objectives of the trial include: 1) lifestyle (eg, sleep,
physical activity, nutrition) change and disease management;
2) enhancement of quality of life; and 3) change in behavioral
habits and personal flexibility. The assessment of these
objectives will be performed using standardized and validated
questionnaires (Table 1). In addition, purpose designed
questionnaires will be administered to evaluate changes in
objective #3. Furthermore, objective measures (ie, data from
devices used by the intervention group) will be employed to
evaluate changes in lifestyle variables. However, this will be
done only within the intervention group since the “care as usual”
group will not receive any devices.
Secondary Objectives
Secondary objectives will include: 1) assessment of satisfaction,
usability, and acceptance of the intervention (tools); 2)
evaluation of the cost-effectiveness of the intervention; and 3)
evaluation of changes in health care consumption. Objective #1
will be achieved through validated questionnaires and qualitative
interviews with end users and their caregivers (if applicable)
and objective #2 will be evaluated using standardized and
validated questionnaires only (Table 1). Objective #3 will be
assessed using a purpose designed questionnaire.
Exploratory Objectives
The current trial will also cover a number of exploratory
objectives where the focus will be on 1) identifying subgroups
of patients who might benefit the most from this intervention
based on their profile (eg, psychological and/or disease profile);
2) evaluating the effects of the intervention on the
electrocardiogram (ECG) data; and 3) gaining more insight in
patients sleep patterns and physical activity over a prolonged
period of time. These objectives will mainly serve the
development of our new hypothesis regarding successful
lifestyle change and will be tested using latent class analysis
(LatentGold 5.0).
Intervention Versus Care as Usual
Intervention
The Do CHANGE intervention consists of different components,
which can be used to provide care that meets patients’ needs.
All patients included in the intervention group will be provided
with the following technology: CarePortal, Moves app, Do
Something Different (behavioral program), Beddit, Fitbit, blood
pressure monitor, COOKiT, and Vire (the Do CHANGE app).
In addition, disease-specific tools will only be provided to those
who need them (ie, weight scale and/or FLUiT). Based on
patients’ primary diagnosis (HF, CAD, or HT) the tools that
might be useful will be recommended by the cardiologist. For
example, patients with HF will receive a weight scale, since this
can assist with monitoring sudden weigh gain, which might be
an indication of deteriorating cardiac function. Figure 2 provides
a schematic overview of the intervention components. To
decrease patient burden, the COOKiT and FLUiT will be
introduced to patients two months postbaseline measurement.
Do Something Different
All patients randomized to the intervention group will receive
the DSD program, which has previously been developed to
change behavioral habits and flexibility [13]. For the current
trial, the program has been adapted to cardiac patients’ needs
and profiles to meet the lifestyle recommendations of this
specific population.
The program challenges patients to step out of their comfort
zone by sending behavioral prompts (Do’s) such as “Explore
more today instead of going the same old way, take a different
route. Look around, spot ten things you wouldn't see on your
usual journey.” By breaking the old unhealthy habits, patients
are expected to be more flexible and able to change their
behavior. The program aims to change behavioral habits,
increase flexibility, and subsequently change habits associated
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with an unhealthy lifestyle and distress, which are both found
to be associated with hypertension and cardiovascular risks.
“Typical” behavioral risks have been identified and are
addressed within the program. To further adapt the program to
patients’ needs, all patients, prior to starting the program, will
be assessed regarding their daily functioning, distress, and
personality such that the Do’s will match their personal
(unhealthy) habits and challenge them to change.
After assessing patients’ personality profile, the intervention
will be provided for 11 weeks. Patients will receive a total of
32 Do’s messages during this period. Also, 16 ToDo’s will be
delivered to the patients based on their current functioning (eg,
if a patient is not performing sufficient exercise, based on the
Fitbit data, he/she will receive a Do based on that). Patients will
receive their Do’s and ToDo’s through the care portal, the Do
CHANGE app and via short message service, depending on
patients’ preferences.
The intervention group will also receive some devices which
will help them to monitor their health behaviors and give them
some insight into their daily functioning. These devices will
include:
CarePortal
The intervention group will also receive a CarePortal (Docobo
Ltd), which will be installed at their home. The CarePortal is a
clinically certified portable device that will allow the patients
to monitor their disease symptoms on a daily basis (ie, by
answering a set of predefined questions every day) and send
these outputs to a health care professional (cardiologist). The
CarePortal will be used to gather ECG data, symptomatic data,
blood pressure, and weight on a daily basis. The patient will be
able to take the ECG measure at any time. By touching the
screen of the CarePortal, the instructions to take the
measurement will appear, guiding the patient step by step to
take the ECG (which will take 2 minutes). The CarePortal will
send the physiological data directly to the cardiologist, who will
be able to view them via an online platform and contact the
patient if necessary. Also, the patients will see their data (the
same data their cardiologist will receive) over a period of 6
months by accessing the online patient portal.
Beddit
To objectively log patients’ sleep data and evaluate whether
their sleep pattern has changed over time, patients assigned to
the intervention group will all receive the Beddit device [16].
Beddit is a certified device to measure sleep, heart rate, and
breathing during time spent in bed. The device has been
validated [17] and is considered one of the most accurate devices
to monitor sleep. For the current trial the Beddit 3 will be used.
Fitbit
Patients’ physical activity will be assessed using the Fitbit “Alta
HR” [24]. The Fitbit Altra HR is a European Conformity
(CE-Marked) activity tracker and can be worn on the wrist.
With the Fitbit, patients’ step count, the intensity of physical
activity, heart rate, calories burned and distance walked will be
assessed. Data from the Fitbit will also be used to initiate
ToDo’s.
Blood Pressure Monitor
All patients in the intervention group will receive the digital
blood pressure monitor, UA-767 Plus, which is a CE-Marked
medical device. Patients will be asked to measure their blood
pressure on a daily basis and log the blood pressure values
through the CarePortal.
COOKiT
COOKiT is a smart spatula that can monitor patients’ cooking
behavior (through a motion sensor which indicates whether the
spatula is used) and measure the salinity—for both sodium and
potassium—of the food that is prepared. The COOKiT has been
developed within Do CHANGE and will be provided to patients
two months postbaseline measurement.
Figure 2. Schematic overview of the Do CHANGE intervention components.
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Vire (Do CHANGE App)
In order for patients not to feel overwhelmed by the apps and
devices that they will have to check every day (if they are
interested in their progress), the Vire app (Do CHANGE app)
has been developed as the integration point. The Vire app was
developed together with end users and health care professionals
to provide an overview of the data gathered by all the devices
that the patients will be using during the study (eg, Beddit, Fitbit,
COOKiT, etc). Through this application, patients will also be
able to receive the Do’s from the DSD program. In addition,
patients will be asked to take pictures (at least 3 per day) of the
food which they have consumed each day (via this app). These
images will automatically be sent to the health care professional
portal (which is also linked to the CarePortal) such that the
health care professional will be able to see what the eating habits
of the patients are.
Moves App
Moves app is an activity and global positioning system tracking
application installed on the mobile phone. The app helps to
provide information useful for assessing the behavioral
indicators—social opportunity, variety, and activity—used for
generating ToDo’s. All patients participating in the intervention
will have to install the Moves app on their mobile phone.
Additional Devices
Dependent on the primary diagnosis, the patient will decide
together with the health care professional which of the following,
additional devices they will be using:
FLUiT
Particularly for patients with HF the FLUiT will be
recommended. FLUiT is a newly developed device in Do
CHANGE which can measure fluid intake. FLUiT is a “smart
sleeve” which can be wrapped around a cup, bottle or glass, and
will gauge the amount of fluid that it contains. It comprises of
an accelerometer and a touch sensor to detect when actual
drinking occurs and will log the quantity drank. FLUiT will be
provided to patients two months postbaseline measures.
Weight Scale
Patients with HF will be provided with a weight scale to monitor
their weight on a daily basis. For the current trial, the Seca Aura
807 model will be used. Patients will be able to communicate
their weight on a daily basis by answering the question on the
CarePortal.
Patients will all be monitored weekly via telephone to make
sure that they are compliant with the program. During these
phone calls, patients will also receive feedback on their eating
habits.
Care as Usual
Patients who are randomized to the comparator group will
receive care as usual. There will be no restrictions on this group.
Patients in this condition are allowed to seek additional care
and also use other tools, which will enhance their disease and
well-being, provided that they report this in the purpose designed
questionnaires at follow-up.
Statistical Analyses
Data will be analyzed using SPSS (IBM statistics 22) and
LatentGold (Version 5.0) [24,25] statistical package. Continuous
and discrete variables will be compared using respectively
Students’ t-test and Chi-square test. The Linear Mixed Models
(LMM) procedure will be performed to evaluate the treatment
effectiveness over time. The LMM procedure is similar to linear
regression analyses except that in LMM the dependent variable
is measured at multiple time points. These analyses will be
adjusted for baseline distress levels. If the interaction effects
are not significant, only the main effects will be entered in the
final model. To examine which patients might benefit from the
intervention based on their profiles, Latent Class Analyses will
be performed [26,27]. An alpha of .05 will be used to indicate
level of significance.
Results
The acquisition of trial data described in this paper is expected
to be finished during the summer of 2018. The following data
analysis and additional publications are expected in the winter
of 2018 and spring 2019.
Discussion
Cardiovascular diseases are the leading cause of death globally,
and they pose a significant burden on current health care systems
[1,28]. Studies have shown that behavioral factors (eg, physical
inactivity, unhealthy diet) account for a large proportion of the
disease burden and thus should be addressed (potentially) by
health care providers [2]. The Do CHANGE trial aims to address
lifestyle behaviors and increase the quality of life of patients
with CAD, HF, and HT. By increasing patients’ behavioral
flexibility and providing them with supportive devices, patients
are expected to break with their unhealthy habits and change
their unhealthy lifestyle in a sustainable manner.
According to Pine & Fletcher [13] there are multiple reasons
why current behavioral programs have not been successful in
changing health behaviors. Firstly, our behavior is only partly
guided by willpower, hence, most patients fail to use willpower
to prevent habitual behaviors (eg, smoking). Secondly, behavior
is often guided by everyday environmental cues which trigger
certain response (eg, having a beer triggers smoking). Finally,
there is a knowledge-doing gap which is demonstrated by the
fact that we often know what is good for our health but we fail
to do it [12,13]. People tend to live by their habits, which can
be stable over time, and seem not to be able to act in accordance
with their knowledge. Hence, within Do CHANGE, we aim to
increase awareness and knowledge about unhealthy behaviors
and at the same time, by using the DSD technique, disrupt habit
chains in daily living. This is expected to boost behavioral
flexibility and enhance behavior change [15].
A total of 250 patients will be recruited from three pilot sites
(Spain, The Netherlands, and Taiwan) and will be randomized
to either the intervention group or care as usual. Patients in the
intervention group will receive the DSD program (for three
months) and will be using devices that will assist them in
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behavior change (for 6 months). Patients will be assessed at
baseline, and at the third and sixth months.
The current trial might face some challenges due to the
international scope and the number of devices that are given to
patients. As patient recruitment will take place in Spain, The
Netherlands, and Taiwan, cultural differences might affect the
outcomes of the trial. Also, due to logistical differences between
the pilot sites, patient recruitment will be slightly different per
site. Although we do not expect this to have a significant impact
on the results, we do consider it as a challenge. Secondly, some
patients will receive multiple devices and/or apps that they are
expected to use for 6 months. This might be perceived as
overwhelming and may potentially lead to lower adherence.
However, the current trial implements a behavior change
component to the intervention, which aims to increase personal
flexibility and enables behavior change. This might lead to more
openness for new behaviors (using devices) and thus improve
adherence.
Do CHANGE will provide insights into lifestyle changes and
the possible mechanism that might drive this change. In addition,
it will give valuable information from objective measures about
patients’ behavioral patterns which, in turn, could serve as input
for future studies that will focus on personalized medicine. This
information will also provide input for the development of future
ecological momentary interventions (real time interventions)
that are focused on providing care to patients whenever and
wherever they prefer it.
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CAD: coronary artery disease
CE-Mark: European Conformity mark
Do CHANGE: Do Cardiac Health: Advanced New Generation Ecosystem
DSD: Do Something Different
ECG: electrocardiogram
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LMM: Linear Mixed Models
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